Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.35 |
| ▸ | TMIGD3 | P0DMS9 | 2/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.34 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.34 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.33 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.32 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | SMPD3 | Q9NY59 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1265703 | 0.83 | CNR1 (0.39) | MAPTALDH1A1KDM4EHPGDMAPK1 | |
| SCHEMBL1193324 | 0.82 | MAPT (0.35) | MAPTALDH1A1KDM4EHPGDMAPK1 | |
| SCHEMBL1234703 | 0.79 | CNR1 (0.39) | MAPTALDH1A1HPGDTMIGD3ADORA2A | |
| SCHEMBL1265853 | 0.78 | MEN1 (0.33) | MAPTALDH1A1KDM4EHPGDMAPK1 | |
| SCHEMBL12895241 | 0.78 | CNR1 (0.53) | MAPTALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL1235880 | 0.78 | CNR2 (0.37) | MAPTALDH1A1KDM4EHPGDMAPK1 | |
| SCHEMBL1193185 | 0.71 | MAPT (0.36) | MAPTALDH1A1KDM4EHPGDMAPK1 | |
| SCHEMBL1236270 | 0.70 | CNR1 (0.48) | MAPTALDH1A1KDM4EHPGDMAPK1 | |
| SCHEMBL1193053 | 0.65 | ALDH1A1 (0.33) | MAPTALDH1A1KDM4EHPGDMAPK1 | |
| SCHEMBL1236041 | 0.64 | CNR1 (0.33) | MAPTALDH1A1HPGDTMIGD3ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8431595-B2 | Furanopyridine cannabinoid compounds and related methods of use | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-04-30 | — | — | US | claimed |
| US-20110046176-A1 | FURANOPYRIDINE CANNABINOID COMPOUNDS AND RELATED METHODS OF USE | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2011-02-24 | — | — | US | claimed |
| US-8431595-B2 | Furanopyridine cannabinoid compounds and related methods of use | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-04-30 | — | — | US | disclosed |
| US-8431595-B2 | Furanopyridine cannabinoid compounds and related methods of use | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-04-30 | — | — | US | disclosed |
| US-8431595-B2 | Furanopyridine cannabinoid compounds and related methods of use | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-04-30 | — | — | US | disclosed |
| US-20110046176-A1 | FURANOPYRIDINE CANNABINOID COMPOUNDS AND RELATED METHODS OF USE | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2011-02-24 | — | — | US | disclosed |
| US-20110046176-A1 | FURANOPYRIDINE CANNABINOID COMPOUNDS AND RELATED METHODS OF USE | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2011-02-24 | — | — | US | disclosed |
| US-20110046176-A1 | FURANOPYRIDINE CANNABINOID COMPOUNDS AND RELATED METHODS OF USE | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2011-02-24 | — | — | US | disclosed |
| WO-2011022692-A2 | FURANOPYRIDINE CANNABINOID COMPOUNDS AND RELATED METHODS OF USE | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE (US) | 2011-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046176-A1 | FURANOPYRIDINE CANNABINOID COMPOUNDS AND RELATED METHODS OF USE | CNR1, CNR2, FAAH | MAPT 4411/4885ALDH1A1 1175/4885KDM4E 2807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.